Effects of subchronic phencyclidine (PCP) treatment on social behaviors, and operant discrimination and reversal learning in C57BL/6J mice

Frontiers in Behavioral Neuroscience

Volumn 3, Issue FEB, 2009, Pages

  Brigman, Jonathan L ^a   Ihne, Jessica ^a   Saksida, Lisa M ^b,c   Bussey, Timothy J ^b,c   Holmes, Andrew ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b UK   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Executive function; Glutamate; Mouse; Negative symptoms; NMDA; Prefrontal cortex; Psychosis; Schizophrenia

Indexed keywords

PHENCYCLIDINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; INSTRUMENTAL CONDITIONING; LEARNING; MALE; MOUSE; NONHUMAN; PSYCHOSOCIAL WITHDRAWAL; SCHIZOPHRENIA; SOCIAL BEHAVIOR; SOCIAL INTERACTION; TASK PERFORMANCE; TREND STUDY; VISUAL DISCRIMINATION;

EID: 77953621538     PISSN: 16625153     EISSN: None     Source Type: Journal    
DOI: 10.3389/neuro.08.002.2009     Document Type: Article

References (70)

1. Abdul-Monim, Z., Neill, J. C. and Reynolds, G. P. (2007). Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbuminimmunoreactive expression in the rat. J. Psychopharmacol. 21, 198-205.
2. Abdul-Monim, Z., Reynolds, G. P., and Neill, J. C. (2003). The atypical antipsychotic ziprasidone, but not haloperidol, improves phencyclidine-induced cognitive deficits in a reversal learning task in the rat. J. Psychopharmacol. 17, 57-65.
3. Abdul-Monim, Z., Reynolds, G. P., and Neill, J. C. (2006). The effect of atypical and classical antipsychotics on subchronic PCP-induced cognitive deficits in a reversal-learning paradigm. Behav. Brain Res. 169, 263-273.
4. Adler, C. M., Malhotra, A. K., Elman, I., Goldberg, T., Egan, M., Pickar, D., and Breier, A. (1999). Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am. J. Psychiatry. 156, 1646-1649.
5. Arguello, P. A., and Gogos, J. A. (2006). Modeling madness in mice: one piece at a time. Neuron 52, 179-196.
6. Barnett, J. H., Sahakian, B. J., Werners, U., Hill, K. E., Brazil, R., Gallagher, O., Bullmore, E. T., and Jones, P. B. (2005). Visuospatial learning and executive function are independently impaired in first-episode psychosis. Psychol. Med. 35, 1031-1041.
7. Birrell, J. M., and Brown, V. J. (2000). Medial frontal cortex mediates perceptual attentional set shifting in the rat. J. Neurosci. 20, 4320-4324.
8. Boyce-Rustay, J. M., and Holmes, A. (2005). Functional roles of NMDA receptor NR2A and NR2B subunits in the acute intoxicating effects of ethanol in mice. Synapse 56, 222-225.
9. Boyce-Rustay, J. M., and Holmes, A. (2006). Ethanol-related behaviors in mice lacking the NMDA receptor NR2A subunit. Psychopharmacology (Berl.) 187, 455-466.
10. Braff, D. L., Heaton, R., Kuck, J., Cullum, M., Moranville, J., Grant, I., and Zisook, S. (1991). The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin Card Sorting Test results. Arch. Gen. Psychiatry. 48, 891-898.
11. Braw, Y., Bloch, Y., Mendelovich, S., Ratzoni, G., Gal, G., Harari, H., Tripto, A. and Levkovitz, Y. (2008). Cognition in young schizophrenia outpatients: comparison of first-episode with multiepisode patients. Schizophr. Bull. 34, 544-554.
12. Brigman, J. L., Bussey, T. J., Saksida, L. M., and Rothblat, L. A. (2005). Discrimination of multidimensional visual stimuli by mice: intra-and extradimensional shifts. Behav. Neurosci. 119, 839-842.
13. Brigman, J. L., Feyder, M., Saksida, L. M., Bussey, T. J., Mishina, M., and Holmes, A. (2008). Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit. Learn. Mem. 15, 50-54.
14. Carter, C. S., Barch, D. M., Buchanan, R. W., Bullmore, E., Krystal, J. H., Cohen, J., Geyer, M., Green, M., Nuechterlein, K. H., Robbins, T., Silverstein, S., Smith, E. E., Strauss, M., Wykes, T., and Heinssen, R. (2008). Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the cognitive neuroscience treatment research to improve cognition in schizophrenia initiative. Biol. Psychiatry 64, 4-10.
15. Crabbe, J. C., Phillips, T. J., Harris, R. A., Arends, M. A., and Koob, G. F. (2006). Alcohol-related genes: contributions from studies with genetically engineered mice. Addict. Biol. 11, 195-269.
16. Crawley, J. N. (2004). Designing mouse behavioral tasks relevant to autisticlike behaviors. Ment. Retard. Dev. Disabil. Res. Rev. 10, 248-258.
17. Crawley, J. N. (2007). Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol. 17, 448-459.
18. Cryan, J. F., and Dev, K. K. (2007). The glutamatergic system as a potential therapeutic target for the treatment of anxiety disorders. In Handbook of Anxiety and Fear, R. J. Blanchard, et al. eds (Amsterdam, Elsevier), pp. 279-302.
19. DSM-IV. (1994). Diagnostic and Statistical Manual of Mental Disorders. Washington, D.C., APA Press.
20. Egerton, A., Reid, L., McGregor, S., Cochran, S. M., Morris, B. J., and Pratt, J. A. (2008). Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats. Psychopharmacology (Berl.) 198, 37-49.
21. Elliott, R., McKenna, P. J., Robbins, T. W., and Sahakian, B. J. (1995). Neuropsychological evidence for frontostriatal dysfunction in schizophrenia. Psychol. Med. 25, 619-630.
22. Hefner, K., Whittle, N., Juhasz, J., Norcross, M., Karlsson, R. M., Saksida, L. M., Bussey, T. J., Singewald, N., and Holmes, A. (2008). Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain. J. Neurosci. 28, 8074-8085.
23. Hutton, S. B., Puri, B. K., Duncan, L. J., Robbins, T. W., Barnes, T. R., and Joyce, E. M. (1998). Executive function in first-episode schizophrenia. Psychol. Med. 28, 463-473.
24. Idris, N. F., Repeto, P., Neill, J. C., and Large, C. H. (2005). Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat. Psychopharmacology (Berl.) 179, 336-348.
25. Izquierdo, A., Wiedholz, L. M., Millstein, R. A., Yang, R. J., Bussey, T. J., Saksida, L. M., and Holmes, A. (2006). Genetic and dopaminergic modulation of reversal learning in a touchscreen-based operant procedure for mice. Behav. Brain Res. 171, 181-188.
26. Jamain, S., Radyushkin, K., Hammerschmidt, K., Granon, S., Boretius, S., Varoqueaux, F., Ramanantsoa, N., Gallego, J., Ronnenberg, A., Winter, D., Frahm, J., Fischer, J., Bourgeron, T., Ehrenreich, H., and Brose, N. (2008). Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc. Natl. Acad. Sci. USA 105, 1710-1715.
27. Jentsch, J. D., Redmond, D. E. Jr., Elsworth, J. D., Taylor, J. R., Youngren, K. D., and Roth, R. H. (1997a). Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science 277, 953-955.
28. Jentsch, J. D., Tran, A., Le, D., Youngren, K. D., and Roth, R. H. (1997b). Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal corticaldependent cognition in the rat. Neuropsychopharmacology 17, 92-99.
29. Jentsch, J. D., and Roth, R. H. (1999). The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 20, 201-225.
30. Jentsch, J. D., Roth, R. H., and Taylor, J. R. (2000). Object retrieval/detour defi-cits in monkeys produced by prior subchronic phencyclidine administration: evidence for cognitive impulsivity. Biol. Psychiatry 48, 415-424.
31. Jentsch, J. D., and Taylor, J. R. (2001). Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats. Neuropsychopharmacology 24, 66-74.
32. Jentsch, J. D., Taylor, J. R., and Roth, R. H. (1998). Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress-and psychostimulant-induced hyperlocomotion. Neuropsychopharmacology 19, 105-113.
33. Joyce, E., Hutton, S., Mutsatsa, S., Gibbins, H., Webb, E., Paul, S., Robbins, T., and Barnes, T. (2002). Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: the West London study. Br. J. Psychiatry 43(Suppl.), s38-s44.
34. Karlsson, R. M., Tanaka, K., Heilig, M., and Holmes, A. (2008). Loss of glial glutamate and aspartate transporter (excitatory amino acid transporter 1) causes locomotor hyperactivity and exaggerated responses to psychotomimetics: rescue by haloperidol and metabotropic glutamate 2/3 agonist. Biol. Psychiatry 64, 810-814.
35. Karlsson, R. M., Tanaka, K., Saksida, L. M., Bussey, T. J., Heilig, M., and Holmes, A. (2009). Assessment of glutamate transporter GLAST (EAAT1) deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia. Neuropsychopharmacology (in press).
36. Krystal, J. H., Karper, L. P., Seibyl, J. P., Freeman, G. K., Delaney, R., Bremner, J. D., Heninger, G. R., Bowers, M. B. Jr., and Charney, D. S. (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51, 199-214.
37. Labrie, V., Lipina, T., and Roder, J. C. (2008). Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia. Psychopharmacology (Berl.) 200, 217-230.
38. Laurent, V., and Podhorna, J. (2004). Subchronic phencyclidine treatment impairs performance of C57BL/6 mice in the attentional set-shifting task. Behav. Pharmacol. 15, 141-148.
39. Lee, P. R., Brady, D. L., Shapiro, R. A., Dorsa, D. M., and Koenig, J. I. (2005). Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin. Neuropsychopharmacology 30, 1883-1894.
40. Li, Z., Kim, C. H., Ichikawa, J., and Meltzer, H. Y. (2003). Effect of repeated administration of phencyclidine on spatial performance in an eight-arm radial maze with delay in rats and mice. Pharmacol. Biochem. Behav. 75, 335-340.
41. Malhotra, A. K., Pinals, D. A., Adler, C. M., Elman, I., Clifton, A., Pickar, D., and Breier, A. (1997). Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17, 141-150.
42. McFarlane, H. G., Kusek, G. K., Yang, M., Phoenix, J. L., Bolivar, V. J., and Crawley, J. N. (2008). Autism-like behavioral phenotypes in BTBR TTTtf/J mice. Genes Brain Behav. 7, 152-163.
43. Miczek, K. A., and Haney, M. (1994). Psychomotor stimulant effects of D-amphetamine, MDMA and PCP: aggressive and schedule-controlled behavior in mice. Psychopharmacology (Berl.) 115, 358-365.
44. Miyamoto, Y., Yamada, K., Noda, Y., Mori, H., Mishina, M., and Nabeshima, T. (2001). Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit. J. Neurosci. 21, 750-757.
45. Mohn, A. R., Gainetdinov, R. R., Caron, M. G., and Koller, B. H. (1999). Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427-436.
46. Morton, A. J., Skillings, E., Bussey, T. J., and Saksida, L. M. (2006). Measuring cognitive deficits in disabled mice using an automated interactive touchscreen system. Nat. Methods 3, 767.
47. Moy, S. S., Nadler, J. J., Young, N. B., Nonneman, R. J., Grossman, A. W., Murphy, D. L., D'Ercole, A. J., Crawley, J. N., Magnuson, T. R., and Lauder, J. M. (2009). Social approach in genetically-engineered mouse lines relevant to autism. Genes Brain Behav. (in press).
48. Murray, G. K., Cheng, F., Clark, L., Barnett, J. H., Blackwell, A. D., Fletcher, P. C., Robbins, T. W., Bullmore, E. T., and Jones, P. B. (2008). Reinforcement and reversal learning in first-episode psychosis. Schizophr. Bull. 34, 848-855.
49. Newcomer, J. W., Farber, N. B., Jevtovic-Todorovic, V., Selke, G., Melson, A. K., Hershey, T., Craft, S., and Olney, J. W. (1999). Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20, 106-118.
50. Palachick, B., Chen, Y. C., Enoch, A. J., Karlsson, R. M., Mishina, M., and Holmes, A. (2008). Role of major NMDA or AMPA receptor subunits in MK-801 potentiation of ethanol intoxication. Alcohol. Clin. Exp. Res. 32, 1479-1492.
51. Pantelis, C., Barber, F. Z., Barnes, T. R., Nelson, H. E., Owen, A. M., and Robbins, T. W. (1999). Comparison of set-shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr. Res. 37, 251-270.
52. Powell, C. M., and Miyakawa, T. (2006). Schizophrenia-relevant behavioral testing in rodent models: a uniquely human disorder? Biol. Psychiatry 59, 1198-1207.
53. Qiao, H., Noda, Y., Kamei, H., Nagai, T., Furukawa, H., Miura, H., Kayukawa, Y., Ohta, T., and Nabeshima, T. (2001). Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment. Neuroreport 12, 11-15.
54. Rodefer, J. S., Murphy, E. R., and Baxter, M. G. (2005). PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats. Eur. J. Neurosci. 21, 1070-1076.
55. Rodefer, J. S., Nguyen, T. N., Karlsson, J. J., and Arnt, J. (2008). Reversal of subchronic PCP-induced deficits in attentional set shifting in rats by sertindole and a 5-HT(6) receptor antagonist: comparison among antipsychotics. Neuropsychopharmacology 33, 2657-2666.
56. Rudebeck, P. H., Walton, M. E., Millette, B. H., Shirley, E., Rushworth, M. F., and Bannerman, D. M. (2007). Distinct contributions of frontal areas to emotion and social behaviour in the rat. Eur. J. Neurosci. 26, 2315-2326.
57. Sams-Dodd, F. (1995). Distinct effects of D-amphetamine and phencyclidine on the social behaviour of rats. Behav. Pharmacol. 6, 55-65.
58. Schoenbaum, G., Roesch, M. R., and Stalnaker, T. A. (2006). Orbitofrontal cortex, decision-making and drug addiction. Trends Neurosci. 29, 116-124.
59. Schwabe, K., Klein, S., and Koch, M. (2006). Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats. Behav. Brain Res. 168, 150-160.
60. Snigdha, S., and Neill, J. C. (2008a). Efficacy of antipsychotics to reverse phencyclidine-induced social interaction deficits in female rats-a preliminary investigation. Behav. Brain Res. 187, 489-494.
61. Snigdha, S., and Neill, J. C. (2008b). Improvement of phencyclidineinduced social behaviour deficits in rats: involvement of 5-HT1A receptors. Behav. Brain Res. 191, 26-31.
62. Stefani, M. R., and Moghaddam, B. (2002). Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat. Behav. Brain Res. 134, 267-274.
63. Tamminga, C. A. (2006). The neurobiology of cognition in schizophrenia. J. Clin. Psychiatry. 67(Suppl. 9), 9-13; Discussion 36-42.
64. Tan, H. Y., Callicott, J. H., and Weinberger, D. R. (2007). Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb. Cortex 17(Suppl. 1), i171-i181.
65. Tanaka, K., Suzuki, M., Sumiyoshi, T., Murata, M., Tsunoda, M., and Kurachi, M. (2003). Subchronic phencyclidine administration alters central vasopressin receptor binding and social interaction in the rat. Brain Res. 992, 239-245.
66. Tyler, C. B., and Miczek, K. A. (1982). Effects of phencyclidine on aggressive behavior in mice. Pharmacol. Biochem. Behav. 17, 503-510.
67. Waltz, J. A., and Gold, J. M. (2007). Probabilistic reversal learning impairments in schizophrenia: further evidence of orbitofrontal dysfunction. Schizophr. Res. 93, 296-303.
68. Wang, D., Noda, Y., Zhou, Y., Nitta, A., Furukawa, H., and Nabeshima, T. (2007). Synergistic effect of galantamine with risperidone on impairment of social interaction in phencyclidine-treated mice as a schizophrenic animal model. Neuropharmacology 52, 1179-1187.
69. Wiedholz, L. M., Owens, W. A., Horton, R. E., Feyder, M., Karlsson, R. M., Hefner, K., Sprengel, R., Celikel, T., Daws, L. C., and Holmes, A. (2008). Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and 'schizophrenia-related' behaviors. Mol. Psychiatry 13, 631-640.
70. Wilmot, C. A., Vanderwende, C., and Spoerlein, M. T. (1987). The effects of phencyclidine on fighting in differentially housed mice. Pharmacol. Biochem. Behav. 28, 341-346.